Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

USA - NYSE:MIR - US60471A1016 - Common Stock

24.6 USD
+1.9 (+8.37%)
Last: 9/18/2025, 8:04:54 PM
24.6 USD
0 (0%)
After Hours: 9/18/2025, 8:04:54 PM
Fundamental Rating

3

Overall MIR gets a fundamental rating of 3 out of 10. We evaluated MIR against 125 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and the financial health of MIR get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, MIR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MIR had positive earnings in the past year.
MIR had a positive operating cash flow in the past year.
MIR had negative earnings in each of the past 5 years.
Each year in the past 5 years MIR had a positive operating cash flow.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

MIR has a Return On Assets (0.37%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 0.68%, MIR is in line with its industry, outperforming 52.80% of the companies in the same industry.
With a Return On Invested Capital value of 1.50%, MIR perfoms like the industry average, outperforming 53.60% of the companies in the same industry.
Industry RankSector Rank
ROA 0.37%
ROE 0.68%
ROIC 1.5%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

MIR has a Profit Margin (1.13%) which is comparable to the rest of the industry.
The Operating Margin of MIR (5.27%) is better than 66.40% of its industry peers.
MIR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 46.70%, MIR is in the better half of the industry, outperforming 79.20% of the companies in the same industry.
In the last couple of years the Gross Margin of MIR has grown nicely.
Industry RankSector Rank
OM 5.27%
PM (TTM) 1.13%
GM 46.7%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MIR is destroying value.
Compared to 1 year ago, MIR has more shares outstanding
MIR has a worse debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MIR has an Altman-Z score of 3.00. This indicates that MIR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MIR (3.00) is worse than 61.60% of its industry peers.
MIR has a debt to FCF ratio of 9.95. This is a negative value and a sign of low solvency as MIR would need 9.95 years to pay back of all of its debts.
MIR's Debt to FCF ratio of 9.95 is in line compared to the rest of the industry. MIR outperforms 53.60% of its industry peers.
MIR has a Debt/Equity ratio of 0.57. This is a neutral value indicating MIR is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.57, MIR is doing worse than 72.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.95
Altman-Z 3
ROIC/WACC0.16
WACC9.42%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

MIR has a Current Ratio of 2.54. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR has a Current ratio (2.54) which is comparable to the rest of the industry.
MIR has a Quick Ratio of 2.01. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR has a Quick ratio of 2.01. This is in the better half of the industry: MIR outperforms 60.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.01
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

MIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.78%, which is quite impressive.
The Revenue has been growing slightly by 7.88% in the past year.
The Revenue has been growing by 14.36% on average over the past years. This is quite good.
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)7.88%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.63%

3.2 Future

The Earnings Per Share is expected to grow by 18.98% on average over the next years. This is quite good.
Based on estimates for the next years, MIR will show a small growth in Revenue. The Revenue will grow by 7.92% on average per year.
EPS Next Y19.62%
EPS Next 2Y18.44%
EPS Next 3Y18.98%
EPS Next 5YN/A
Revenue Next Year8.63%
Revenue Next 2Y8.31%
Revenue Next 3Y7.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 53.48, which means the current valuation is very expensive for MIR.
MIR's Price/Earnings ratio is in line with the industry average.
MIR is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 42.77, the valuation of MIR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as MIR.
MIR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 53.48
Fwd PE 42.77
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MIR's Enterprise Value to EBITDA is on the same level as the industry average.
MIR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 68.77
EV/EBITDA 33.69
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 18.98% in the coming years.
PEG (NY)2.73
PEG (5Y)N/A
EPS Next 2Y18.44%
EPS Next 3Y18.98%

0

5. Dividend

5.1 Amount

No dividends for MIR!.
Industry RankSector Rank
Dividend Yield N/A

MIRION TECHNOLOGIES INC

NYSE:MIR (9/18/2025, 8:04:54 PM)

After market: 24.6 0 (0%)

24.6

+1.9 (+8.37%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-27 2025-10-27
Inst Owners84.58%
Inst Owner Change8.15%
Ins Owners4.41%
Ins Owner Change-2.08%
Market Cap5.76B
Analysts84
Price Target23.46 (-4.63%)
Short Float %6.53%
Short Ratio5.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)8.05%
Max EPS beat(2)26.94%
EPS beat(4)3
Avg EPS beat(4)9.22%
Min EPS beat(4)-11.99%
Max EPS beat(4)26.94%
EPS beat(8)6
Avg EPS beat(8)9.28%
EPS beat(12)8
Avg EPS beat(12)6.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.86%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)2.07%
Revenue beat(4)3
Avg Revenue beat(4)1.25%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)2.76%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)8
Avg Revenue beat(12)1.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.48%
PT rev (3m)22.34%
EPS NQ rev (1m)0.81%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)1.55%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)1.44%
Revenue NY rev (1m)1.66%
Revenue NY rev (3m)1.95%
Valuation
Industry RankSector Rank
PE 53.48
Fwd PE 42.77
P/S 6.5
P/FCF 68.77
P/OCF 45.72
P/B 3.94
P/tB N/A
EV/EBITDA 33.69
EPS(TTM)0.46
EY1.87%
EPS(NY)0.58
Fwd EY2.34%
FCF(TTM)0.36
FCFY1.45%
OCF(TTM)0.54
OCFY2.19%
SpS3.79
BVpS6.25
TBVpS-1.65
PEG (NY)2.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 0.68%
ROCE 1.89%
ROIC 1.5%
ROICexc 1.68%
ROICexgc 10.58%
OM 5.27%
PM (TTM) 1.13%
GM 46.7%
FCFM 9.45%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.71%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.95
Debt/EBITDA 4.44
Cap/Depr 29.99%
Cap/Sales 4.76%
Interest Coverage 0.96
Cash Conversion 67.18%
Profit Quality 837%
Current Ratio 2.54
Quick Ratio 2.01
Altman-Z 3
F-Score8
WACC9.42%
ROIC/WACC0.16
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y19.62%
EPS Next 2Y18.44%
EPS Next 3Y18.98%
EPS Next 5YN/A
Revenue 1Y (TTM)7.88%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.63%
Revenue Next Year8.63%
Revenue Next 2Y8.31%
Revenue Next 3Y7.92%
Revenue Next 5YN/A
EBIT growth 1Y1768%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year481.98%
EBIT Next 3Y96.8%
EBIT Next 5YN/A
FCF growth 1Y542.86%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y696.84%
OCF growth 3Y22.74%
OCF growth 5Y46.47%